Assessment of the Virulence of the Burkholderia mallei Strain BAC 86/19 in BALB/c Mice.
Emanuelle Baldo GasparLenita Ramires Dos SantosAndréa Alves do EgitoMaria Goretti Dos SantosCynthia MantovaniJuliana da Silva Gomes RiegerGuilherme Augusto de Sousa AbrantesPaula Adas Pereira SunigaJúlia de Mendonça FavachoIngrid Batista PintoAlessandra Figueiredo de Castro NassarFernando Leandro Dos SantosFlábio Ribeiro de AraújoPublished in: Microorganisms (2023)
Burkholderia mallei is an aerobic, Gram-negative, non-motile bacillus. As an obligate mammalian pathogen, it primarily affects solipeds. Although rarely transmitted to humans, the disease it causes, glanders, is classified as a zoonosis. The bacterium was officially eradicated in Brazil in 1969; however, it reemerged after three decades. This study aims to assess the virulence of a specific B. mallei strain, isolated in Brazil, in BALB/c mice through intranasal infection. The strain, B. mallei BAC 86/19, was obtained from the tracheal secretion of a young mare displaying positive serology but no clinical signs of glanders. Post-mortem examinations revealed macroscopic lesions consistent with the disease, however. In mice, the LD 50 was determined to be approximately 1.59 × 10 5 colony-forming units (CFU)/animal. Mice exposed to either 0.1 × LD 50 or 1 × LD 50 displayed transient weight loss, which resolved after three or five days, respectively. B. mallei persisted within the liver and lung for five days post-infection and in the spleen for seven days. These findings underscore the detectable virulence of the Brazilian B. mallei BAC 86/19 strain in mice, which are relatively resilient hosts. This research points to the importance of the continued investigation of the virulence mechanisms and potential countermeasures associated with B. mallei infections, including their Brazilian isolates.
Keyphrases
- high fat diet induced
- escherichia coli
- pseudomonas aeruginosa
- staphylococcus aureus
- gram negative
- antimicrobial resistance
- biofilm formation
- weight loss
- multidrug resistant
- type diabetes
- wild type
- cystic fibrosis
- candida albicans
- brain injury
- risk assessment
- metabolic syndrome
- subarachnoid hemorrhage
- skeletal muscle
- human health
- gastric bypass